Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stearns

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Immunology|May 30, 2002
Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosisM M Boomsma, D J Stearns-Kurosawa, C A Stegeman, et al.
The American Journal of Pathology|February 14, 2013
Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndromeDeborah J Stearns-Kurosawa, Sun-Young Oh, Rama P Cherla, et al.
Blood|February 26, 2000
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsisF B Taylor, D J Stearns-Kurosawa, S Kurosawa, et al.
The Journal of Biological Chemistry|May 16, 1998
A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificityM D Smirnov, O Safa, L Regan, et al.
Anesthesiology|December 24, 2009
Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer painRobert J Coffey, Mary L Owens, Steven K Broste, et al.
JAMA Network Open|April 6, 2019
Assessment of Health Care Utilization and Cost of Targeted Drug Delivery and Conventional Medical Management vs Conventional Medical Management Alone for Patients With Cancer-Related PainLisa J Stearns, Sanjeet Narang, Robert E Albright, et al.
Pain Medicine (Malden, Mass.)|July 21, 2010
Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer painRobert J Coffey, Mary L Owens, Steven K Broste, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health StudyA P Reiner, C L Carty, N S Jenny, et al.
Thrombosis and Haemostasis|December 22, 1999
Endothelial protein C receptorC T Esmon, J Xu, J M Gu, et al.
Plos One|April 18, 2019
A computational solution to improve biomarker reproducibility during long-term projectsFeng Feng, Morgan P Thompson, Beena E Thomas, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Immunology|May 30, 2002
Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosisM M Boomsma, D J Stearns-Kurosawa, C A Stegeman, et al.
The American Journal of Pathology|February 14, 2013
Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndromeDeborah J Stearns-Kurosawa, Sun-Young Oh, Rama P Cherla, et al.
Blood|February 26, 2000
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsisF B Taylor, D J Stearns-Kurosawa, S Kurosawa, et al.
The Journal of Biological Chemistry|May 16, 1998
A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificityM D Smirnov, O Safa, L Regan, et al.
Anesthesiology|December 24, 2009
Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer painRobert J Coffey, Mary L Owens, Steven K Broste, et al.
JAMA Network Open|April 6, 2019
Assessment of Health Care Utilization and Cost of Targeted Drug Delivery and Conventional Medical Management vs Conventional Medical Management Alone for Patients With Cancer-Related PainLisa J Stearns, Sanjeet Narang, Robert E Albright, et al.
Pain Medicine (Malden, Mass.)|July 21, 2010
Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer painRobert J Coffey, Mary L Owens, Steven K Broste, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health StudyA P Reiner, C L Carty, N S Jenny, et al.
Thrombosis and Haemostasis|December 22, 1999
Endothelial protein C receptorC T Esmon, J Xu, J M Gu, et al.
Plos One|April 18, 2019
A computational solution to improve biomarker reproducibility during long-term projectsFeng Feng, Morgan P Thompson, Beena E Thomas, et al.
Pageof 7